Budget impact analysis of multiple varicella vaccination strategies: a Mexico perspective

References

• Bardach A, Cafferata ML, Klein K, Cormick G, Gibbons L, Ruvinsky S. Incidence and use of resources for chickenpox and herpes zoster in Latin America and the Caribbean–a systematic review and meta-analysis. Pediatr Infect Dis J. 2012 Dec;31(12):1263–68. doi:10.1097/INF.0b013e31826ff3a5.
   PubMed Web of Science ®Google Scholar
• Heininger U, Seward JF. Varicella. Lancet. 2006 Oct 14;368(9544):1365–76. doi:10.1016/S0140-6736(06)69561-5.
   PubMed Web of Science ®Google Scholar
• Sadzot-Delvaux C, Rentier B, Wutzler P, Asano Y, Suga S, Yoshikawa T, Plotkin SA. Varicella vaccination in Japan, South Korea, and Europe. J Infect Dis. 2008 Mar 1;197(Suppl 2):S185–190. doi:10.1086/522163.
   PubMedGoogle Scholar
• Davis MM, Patel MS, Gebremariam A. Decline in varicella-related hospitalizations and expenditures for children and adults after introduction of varicella vaccine in the United States. Pediatrics. 2004 Sep;114(3):786–92. doi:10.1542/peds.2004-0012.
   PubMed Web of Science ®Google Scholar
• Nguyen HQ, Jumaan AO, Seward JF. Decline in mortality due to varicella after implementation of varicella vaccination in the United States. N Engl J Med. 2005 Feb 3;352(5):450–58. doi:10.1056/NEJMoa042271.
   PubMed Web of Science ®Google Scholar
• Lopez AS, Zhang J, Brown C, Bialek S. Varicella-related hospitalizations in the United States, 2000–2006: the 1-dose varicella vaccination era. Pediatrics. 2011 Feb;127(2):238–45. doi:10.1542/peds.2010-0962.
   PubMed Web of Science ®Google Scholar
• Zhou F, Harpaz R, Jumaan AO, Winston CA, Shefer A. Impact of varicella vaccination on health care utilization. JAMA. 2005 Aug 17;294(7):797–802. doi:10.1001/jama.294.7.797.
   PubMed Web of Science ®Google Scholar
• Marin M, Zhang JX, Seward JF. Near elimination of varicella deaths in the US after implementation of the vaccination program. Pediatrics. 2011 Aug;128(2):214–20. doi:10.1542/peds.2010-3385.
   PubMed Web of Science ®Google Scholar
• Kwong JC, Tanuseputro P, Zagorski B, Moineddin R, Chan KJ. Impact of varicella vaccination on health care outcomes in Ontario, Canada: effect of a publicly funded program? Vaccine. 2008 Nov 5;26(47):6006–12.
   PubMed Web of Science ®Google Scholar
• Avila-Aguero ML, Beltran S, Castillo JBD, Castillo Díaz ME, Chaparro LE, Deseda C, Debbag R, Espinal C, Falleiros-Arlant LH, González Mata AJ, et al. Varicella epidemiology in Latin America and the Caribbean. Expert Rev Vaccines. 2018 Feb;17(2):175–83. doi:10.1080/14760584.2018.1418327.
   PubMed Web of Science ®Google Scholar
• Cabrera GDA, Muños MW, Gómez ACM. Comportamiento epidemiológico de la varicela en Mexico: 18 años de estudios y estimaciones para los proximos cinco años. Revista de Enfermedades Infecciosas en Pediatría. 2009;22:77–82.
   Google Scholar
• Centers for Disease Control & Prevention. Binational immunization resource tool for children from birth through 18 years. 2018 Jan [accessed 2018 Aug 1]. https://www.cdc.gov/vaccines/schedules/downloads/child/binational-schedule-pr.pdf.
   Google Scholar
• SLIPE. Prevención de Varicela en América Latina y el Caribe. Varicella Task Force – Documento de Posición de la SLIPE. [accessed 2018 Aug 1]. https://www.the-ahf.org/sites/default/files/FINAL%20-%20Varicella%20Position%20Paper%20June%2020%202016.pdf.
   Google Scholar
• Thiry N, Beutels P, Van Damme P, Van Doorslaer E. Economic evaluations of varicella vaccination programmes: a review of the literature. Pharmacoeconomics. 2003;21(1):13–38. doi:10.2165/00019053-200321010-00002.
   PubMed Web of Science ®Google Scholar
• Hammerschmidt T, Bisanz H, Wutzler P. Universal mass vaccination against varicella in Germany using an MMRV combination vaccine with a two-dose schedule: an economic analysis. Vaccine. 2007 Oct 16;25(42):7307–12. doi:10.1016/j.vaccine.2007.08.017.
   PubMed Web of Science ®Google Scholar
• Rozenbaum MH, van Hoek AJ, Vegter S, Postma MJ. Cost-effectiveness of varicella vaccination programs: an update of the literature. Expert Rev Vaccines. 2008 Aug;7(6):753–82. doi:10.1586/14760584.7.6.753.
   PubMed Web of Science ®Google Scholar
• Soarez PC, Novaes HM, Sartori AM. Impact of methodology on the results of economic evaluations of varicella vaccination programs: is it important for decision-making? Cad Saude Publica. 2009;25(Suppl 3):S401–414. doi:10.1590/s0102-311x2009001500006.
   PubMedGoogle Scholar
• Unim B, Saulle R, Boccalini S, Taddei C, Ceccherini V, Boccia A, Bonanni P, La Torre G. Economic evaluation of varicella vaccination: results of a systematic review. Hum Vaccin Immunother. 2013 Sep;9(9):1932–42. doi:10.4161/hv.25228.
   PubMed Web of Science ®Google Scholar
• Carvalho N, Jit M, Cox S, Yoong J, Hutubessy RCW. Capturing budget impact considerations within economic evaluations: a systematic review of economic evaluations of rotavirus vaccine in low- and middle-income countries and a proposed assessment framework. Pharmacoeconomics. 2018 Jan;36(1):79–90. doi:10.1007/s40273-017-0569-2.
   PubMed Web of Science ®Google Scholar
• Loze PM, Nasciben LB, Sartori AMC, Itria A, Novaes HMD, de Soarez PC. Vaccines are different: a systematic review of budget impact analyses of vaccines. Vaccine. 2017 May 15;35(21):2781–93. doi:10.1016/j.vaccine.2017.03.088.
   PubMed Web of Science ®Google Scholar
• Schuette MC, Hethcote HW. Modeling the effects of varicella vaccination programs on the incidence of chickenpox and shingles. Bull Math Biol. 1999 Nov;61(6):1031–64.
   PubMed Web of Science ®Google Scholar
• Brisson M, Melkonyan G, Drolet M, De Serres G, Thibeault R, De Wals P. Modeling the impact of one- and two-dose varicella vaccination on the epidemiology of varicella and zoster. Vaccine. 2010 Apr 26;28(19):3385–97. doi:10.1016/j.vaccine.2010.02.079.
   PubMed Web of Science ®Google Scholar
• van Hoek AJ, Melegaro A, Zagheni E, Edmunds WJ, Gay N. Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England. Vaccine. 2011 Mar 16;29(13):2411–20. doi:10.1016/j.vaccine.2011.01.037.
   PubMed Web of Science ®Google Scholar
• Wolfson LJ, Daniels VJ, Pillsbury M, Kurugöl Z, Yardimci C, Kyle J, Dinleyici EC, Verjans GMGM. Cost-effectiveness analysis of universal varicella vaccination in Turkey using a dynamic transmission model. PLoS One. 2019;14(8):e0220921. doi:10.1371/journal.pone.0220921.
   PubMed Web of Science ®Google Scholar
• Documento metodológico: proyecciones de la población de México 2010–2050. México: Consejo Nacional de Población; 2012. https://www.gob.mx/cms/uploads/attachment/file/63977/Documento_Metodologico_Proyecciones_Mexico_2010_2050.pdf.
   Google Scholar
• Conde-Glez C, Lazcano-Ponce E, Rojas R, DeAntonio R, Romano-Mazzotti L, Cervantes Y, Ortega-Barria E. Seroprevalences of varicella-zoster virus, herpes simplex virus and cytomegalovirus in a cross-sectional study in Mexico. Vaccine. 2013 Oct 17;31(44):5067–74. doi:10.1016/j.vaccine.2013.08.077.
   PubMed Web of Science ®Google Scholar
• Kuter B, Matthews H, Shinefield H, Black S, Dennehy P, Watson B, Reisinger K, Kim LL, Lupinacci L, Hartzel J, et al. Ten year follow-up of healthy children who received one or two injections of varicella vaccine. Pediatr Infect Dis J. 2004 Feb;23(2):132–37. doi:10.1097/01.inf.0000109287.97518.67.
   PubMed Web of Science ®Google Scholar
• Ouwens MJ, Littlewood KJ, Sauboin C, Téhard B, Denis F, Boëlle P-Y, Alain S. The impact of 2-dose routine measles, mumps, rubella, and varicella vaccination in France on the epidemiology of varicella and zoster using a dynamic model with an empirical contact matrix. Clin Ther. 2015 Apr 1;37(4):816–829 e810. doi:10.1016/j.clinthera.2014.12.017.
   PubMed Web of Science ®Google Scholar
• Holl K, Sauboin C, Amodio E, Bonanni P, Gabutti G. Coverage, efficacy or dosing interval: which factor predominantly influences the impact of routine childhood vaccination for the prevention of varicella? A model-based study for Italy. BMC Public Health. 2016 Oct 21;16(1):1103. doi:10.1186/s12889-016-3738-x.
   PubMed Web of Science ®Google Scholar
• Oh SH, Choi EH, Shin SH, Kim Y-K, Chang JK, Choi KM, Hur JK, Kim K-H, Kim JY, Chung EH, et al. Varicella and varicella vaccination in South Korea. Clin Vaccine Immunol. 2014 May;21(5):762–68. doi:10.1128/CVI.00645-13.
   PubMed Web of Science ®Google Scholar
• Lee YH, Choe YJ, Cho SI, Kang CR, Bang JH, Oh MD, Lee JK. Effectiveness of varicella vaccination program in preventing laboratory-confirmed cases in children in Seoul, Korea. J Korean Med Sci. 2016 Dec;31(12):1897–901. doi:10.3346/jkms.2016.31.12.1897.
   PubMed Web of Science ®Google Scholar
• Sullivan SD, Mauskopf JA, Augustovski F, Jaime Caro J, Lee KM, Minchin M, Orlewska E, Penna P, Rodriguez Barrios J-M, Shau W-Y. Budget impact analysis-principles of good practice: report of the ISPOR 2012 budget impact analysis good practice II task force. Value Health. 2014 Jan–Feb;17(1):5–14. doi:10.1016/j.jval.2013.08.2291.
   PubMed Web of Science ®Google Scholar
• Instituto Mexicano Del Seguro Social. IMSS comprό. [accessed 2017 July 21]. http://compras.imss.gob.mx/.
   Google Scholar
• Portnoy A, Ozawa S, Grewal S, Norman BA, Rajgopal J, Gorham KM, Haidari LA, Brown ST, Lee BY. Costs of vaccine programs across 94 low- and middle-income countries. Vaccine. 2015 May 7;33(Suppl 1):A99–108. doi:10.1016/j.vaccine.2014.12.037.
   PubMedGoogle Scholar
• Secretaria de gobernacio: Diario Oficial De La Federación. Costos Unitarios por Nivel de Atención Médica. [accessed 2017 July 21.]. http://www.dof.gob.mx/nota_detalle.php?codigo=5476988&fecha=21/03/2017.
   Google Scholar
• Rampakakis E, Pollock C, Vujacich C, Toniolo Neto J, Ortiz Covarrubias A, Monsanto H, Johnson KD. Economic burden of herpes zoster (“Culebrilla”) in Latin America. Int J Infect Dis. 2017 May;58:22–26. doi:10.1016/j.ijid.2017.02.021.
   PubMed Web of Science ®Google Scholar
• CCEMG - EPPI-Centre. CCEMG - EPPI-Centre Cost Converter. 2016 Apr 29 [accessed 2018 May 15]. https://eppi.ioe.ac.uk/costconversion/.
   Google Scholar
• Vergara-Castaneda A, Escobar-Gutierrez A, Ruiz-Tovar K, Sotelo J, Ordoñez G, Cruz-Rivera MY, Fonseca-Coronado S, Martinez-Guarneros A, Carpio-Pedroza JC, Vaughan G. Epidemiology of varicella in Mexico. J Clin Virol. 2012 Sep;55(1):51–57. doi:10.1016/j.jcv.2012.06.004.
   PubMed Web of Science ®Google Scholar
• Mauskopf J, Earnshaw S. A methodological review of US budget-impact models for new drugs. Pharmacoeconomics. 2016 Nov;34(11):1111–31. doi:10.1007/s40273-016-0426-8.
   PubMed Web of Science ®Google Scholar
• Lopez AS, Zhang J, Marin M. Epidemiology of varicella during the 2-dose varicella vaccination program - United States, 2005–2014. MMWR Morb Mortal Wkly Rep. 2016 Sep 2;65(34):902–05. doi:10.15585/mmwr.mm6534a4.
   PubMed Web of Science ®Google Scholar
• Wolfson LJ, Daniels VJ, Altland A, Black W, Huang W, Ou W. The impact of varicella vaccination on the incidence of varicella and herpes zoster in the United States: updated evidence from observational databases, 1991–2016. Clin Infect Dis. 2019 Apr 24. doi:10.1093/cid/ciz305.
   PubMed Web of Science ®Google Scholar
• Hill HA, Elam-Evans LD, Yankey D, Singleton JA, Kang Y. Vaccination coverage among children aged 19–35 months - United States, 2016. MMWR Morb Mortal Wkly Rep. 2017 Nov 3;66(43):1171–77. doi:10.15585/mmwr.mm6643a3.
   PubMed Web of Science ®Google Scholar
• Hyman JM. Disease transmission models with biased partnership selection. Appl Numer Math. 1997;24(2–3):379–92. doi:10.1016/S0168-9274(97)00034-2.
   Web of Science ®Google Scholar
• Kiss IZ, Green DM, Kao RR. The effect of network mixing patterns on epidemic dynamics and the efficacy of disease contact tracing. J R Soc Interface. 2008 Jul 6;5(24):791–99. doi:10.1098/rsif.2007.1272.
   PubMed Web of Science ®Google Scholar
• Secretaría de Salud. Sistema Nacional de Vigilancia Epidemiologíca- Epidemiología. [accessed 2019 Feb 14]. https://www.gob.mx/salud/acciones-y-programas/direccion-general-de-epidemiologia-boletin-epidemiologico.
   Google Scholar
• Secretaría de Salud. Dirección General de Epidemiología Anuario de Morbilidad 1984–2017. [accessed 2017 Sep 1]. http://www.epidemiologia.salud.gob.mx/anuario/html/anuarios.html.
   Google Scholar
• Monsanto H, Cashat M, Kyle J, Perez-Bolde C, Pillsbury M, Weiss TJ, Wolfson LJ. The implications of vaccine characteristics and private sector vaccination on varicella: a model-based analysis for Mexico. Paper presented at: ISPOR Latin America; 2017; Sao Paolo, Brazil. doi:10.1016/j.jval.2017.08.3011.
   Google Scholar
• Bernstein HH, Rothstein EP, Watson BM, Reisinger KS, Blatter MM, Wellman CO, Chartrand SA, Cho I, Ngai A, White CJ. Clinical survey of natural varicella compared with breakthrough varicella after immunization with live attenuated Oka/Merck varicella vaccine. Pediatrics. 1993 Dec;92(6):833–37.
   PubMed Web of Science ®Google Scholar